Zhejiang CONBA Pharmaceutical Co.,Ltd.
Shanghai Stock Exchange 600572.SS
Zhejiang CONBA Pharmaceutical Co.,Ltd. EBITDA for the year ending December 31, 2023: USD 158.94 M
-
Zhejiang CONBA Pharmaceutical Co.,Ltd. EBITDA for the year ending December 31, 2022 was USD 132.88 M, a -70.75% change year over year.
-
Zhejiang CONBA Pharmaceutical Co.,Ltd. EBITDA for the year ending December 31, 2021 was USD 454.29 M, a 140.03% change year over year.
-
Zhejiang CONBA Pharmaceutical Co.,Ltd. EBITDA for the year ending December 31, 2020 was USD 189.26 M, a 168.45% change year over year.
-
Zhejiang CONBA Pharmaceutical Co.,Ltd. EBITDA for the year ending December 31, 2019 was USD 70.50 M, a -64.64% change year over year.
| Date | EBITDA | Net Income | EPS (Diluted) | Shares (Diluted, Weighted) |
|---|
| CEO | Mr. Guoliang Luo |
| IPO Date | April 12, 2004 |
| Location | China |
| Headquarters | No. 568, Binkang Road |
| Employees | 8,411 |
| Sector | Health Care |
| Industries | |
Zhejiang CONBA Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of traditional Chinese medicines and botanical products in China. It offers chemical medicines, Chinese patent medicines, eye health products, nutritional supplements, health supplies, healthy daily necessities and food products, and other personal care products. The company was formerly known as Lanxi Yunshan Pharmaceutical Factory and changed its name to Zhejiang CONBA Pharmaceutical Co.,Ltd. in October 1999. Zhejiang CONBA Pharmaceutical Co.,Ltd. was founded in 1969 and is headquartered in Hangzhou, China. Zhejiang CONBA Pharmaceutical Co.,Ltd. is a subsidiary of Zhejiang Traditional Chinese Medicine Health Industry Group Co., Ltd.
Past 5 years
USD 0.31
USD 1.91
USD 2.17
USD 1.79
USD 0.47
StockViz Staff
January 15, 2025
Any question? Send us an email